NDC Code(s) : 16729-035-10, 16729-035-15, 16729-035-16, 16729-035-17
Packager : Accord Healthcare Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
| AnastrozoleAnastrozole TABLET | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| LABELER - Accord Healthcare Inc.(604222237) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Intas Pharmaceuticals Limited | 725927649 | manufacture(16729-035), analysis(16729-035) | |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Intas Pharmaceuticals Limited | 915837971 | manufacture(16729-035), analysis(16729-035) | |
PRINCIPAL DISPLAY PANEL
30 Tablets








